Share price
$8.19
▲ 52.51% vs. $5.37 prior close
Autonomix Medical Shares Surge 52% After $4.9 Million Warrant Agreement Alters Dilution Outlook
Shares of Autonomix Medical, Inc. surged 52.51% on Tuesday following a $4.9 million warrant exercise that provided the pre-revenue device maker with additional funds.
:root{color-scheme:dark;--bg:#08111c;--panel:#101c2a;--panel2:#142437;--ink:#eef6ff;--muted:#93a7bd;--line:#263a51;--cyan:#39c6dc;--green:#55d68b;--amber:#f6b94a;--red:#ff7780}*{box-sizing:border-box}body{margin:0;background:linear-gradient(145deg,#07101a,#0b1724 52%,#08131e);color:var(--ink);font-family:Inter,ui-sans-serif,system-ui,-apple-system,Segoe UI,sans-serif}.dash{max-width:1120px;margin:auto;padding:22px}.eyebrow{font-size:12px;letter-spacing:.13em;text-transform:uppercase;color:var(--cyan);font-weight:800}.top{display:flex;justify-content:space-between;gap:20px;align-items:end;margin:6px 0 16px}.top h1{font-size:clamp(25px,4vw,42px);line-height:1.03;margin:0}.stamp{color:var(--muted);font-size:12px;text-align:right}.grid{display:grid;grid-template-columns:repeat(12,1fr);gap:12px}.card{background:linear-gradient(180deg,rgba(20,36,55,.96),rgba(13,25,38,.96));border:1px solid var(--line);border-radius:15px;padding:16px;box-shadow:0 14px 34px rgba(0,0,0,.18)}.metric{grid-column:span 3}.wide{grid-column:span 8}.side{grid-column:span 4}.half{grid-column:span 6}.label{font-size:11px;text-transform:uppercase;letter-spacing:.1em;color:var(--muted)}.value{font-size:30px;font-weight:850;margin:6px 0 2px}.sub{font-size:12px;color:var(--muted)}.up{color:var(--green)}.warn{color:var(--amber)}h2{font-size:16px;margin:0 0 12px}p{font-size:13px;line-height:1.5;color:#cad8e7;margin:8px 0}.barrow{display:grid;grid-template-columns:150px 1fr 78px;gap:10px;align-items:center;margin:11px 0;font-size:12px}.track{height:10px;background:#203247;border-radius:20px;overflow:hidden}.fill{height:100%;border-radius:20px;background:linear-gradient(90deg,var(--cyan),#6e9cff)}.fill.green{background:linear-gradient(90deg,#39b879,var(--green))}.fill.amber{background:linear-gradient(90deg,#e58e33,var(--amber))}table{width:100%;border-collapse:collapse;font-size:12px}th,td{text-align:left;padding:9px 7px;border-bottom:1px solid var(--line)}th{color:var(--muted);font-weight:650}td:last-child,th:last-child{text-align:right}.pill{display:inline-block;padding:4px 8px;border-radius:99px;background:#203a4a;color:#81ddeb;font-size:11px}.risk{border-left:3px solid var(--red)}.timeline{display:grid;gap:10px}.event{display:grid;grid-template-columns:94px 12px 1fr;gap:9px;align-items:start}.dot{width:10px;height:10px;border-radius:50%;background:var(--cyan);margin-top:4px;box-shadow:0 0 0 4px rgba(57,198,220,.12)}.event b{font-size:12px}.event span{font-size:12px;color:var(--muted)}svg{width:100%;height:auto;display:block}.foot{margin-top:12px;color:var(--muted);font-size:10px;line-height:1.4}@media(max-width:760px){.metric,.wide,.side,.half{grid-column:span 12}.top{display:block}.stamp{text-align:left;margin-top:8px}.barrow{grid-template-columns:120px 1fr 64px}.dash{padding:14px}}Autonomix Medical
NASDAQ: AMIX · Stock move
Autonomix Medical
financing math
Market open snapshot
August 25, 2026 · 09:50:42 EDT
August 25, 2026 · 09:50:42 EDT
Volume
11.0M
2.77× 3-month average
Quoted market cap
$7.95M
Yahoo Finance intraday
Gross cash
$4.9M
Before fees and expenses
The deal is large on both sides of the ledger
The immediate raise equals about 142% of June cash and 61.6% of the quoted market value. Future warrant cash requires exercise and is not assured.
Capital structure
| Instrument | Shares |
|---|---|
| Existing warrants exercised | 857,462 |
| New E-1 warrants | 535,913 |
| New E-2 warrants | 535,913 |
| Replacement coverage | 125% |
New warrants strike at $6.25 and expire five years after issuance.
Share-count sensitivity
0.971M1.829M2.900MAug. 6 reportedAfter exerciseIf new warrants exerciseIllustrative only; excludes other securities and any share changes after August 6.
Balance-sheet pressure
| June quarter | Value |
|---|---|
| Revenue | $0 |
| Net loss | $2.7M |
| Cash used in operations | $3.5M |
| Working capital | $3.1M |
| Funding need to commercialization | $25M–$30M |
The warrant cash helps, but it does not close the disclosed long-term financing gap.
What moved the shares
Aug. 24Company announces exercise of 857,462 warrants at $5.75.
Aug. 25AMIX opens at $7.60 and trades between $7.38 and $8.73 by 09:50 EDT.
Aug. 26Expected closing, subject to customary conditions.
Five yearsNew E-1 and E-2 warrants remain exercisable at $6.25.
Analyst signal
Sparse coverage
$58.80
Two-analyst average target
Maxim Group: Buy, $42 target. Latest cited update: June 2, 2026. Targets predate this financing and carry high uncertainty.
Investor bridge
The immediate cash can fund clinical and device work. The stock's 52.5% gain prices that liquidity quickly. Existing holders must weigh it against an immediate share increase and a larger replacement-warrant overhang.
Risks
Closing conditions, further equity raises, clinical execution, FDA timing, sparse liquidity and a going-concern disclosure all matter. The technology is investigational and has not been cleared for U.S. marketing.
Sources: Autonomix Medical announcement dated August 24, 2026; Yahoo Finance AMIX quote at August 25, 2026, 09:50:42 EDT; Autonomix June-quarter filing; StockAnalysis analyst data last updated June 2, 2026. Calculations are TS2 estimates from disclosed figures and are rounded.
Autonomix Medical Soars 434% as Patent Filings Indicate 2025 Grant – The Wall Street Journal
Shares of Autonomix Medical, Inc. surged 434% on Tuesday following disclosure of a patent that had been issued ten months prior. The sharp increase in stock price, not the patent’s original award date, altered the company’s financial outlook.
Autonomix Medical (NASDAQ:AMIX) Shares Surge 400% Following Patent Update Linked to a 2025 Grant
Shares of Autonomix Medical Inc. surged nearly fivefold on Tuesday following the announcement of a cancer-neuromodulation patent. However, federal records indicate the relevant U.S. grant is dated October 2025.
Autonomix Medical, Inc. (NASDAQ:AMIX) rises as cash-per-share differential aligns with warrant overhang
Autonomix Medical shares jumped ahead of Wednesday's market open following a balance-sheet update that revealed a significant valuation disparity. Nasdaq trading was shut during regular hours. By 5:55 a.m., premarket volume totaled 3.31 million shares.
Autonomix Medical (AMIX) Stock Doubles on New Pancreatic Cancer Quality‑of‑Life Data – November 17, 2025 Update
As of this afternoon on November 17, 2025, all company‑specific news about Autonomix Medical, Inc. centers on the same core development: new quality‑of‑life data from its pancreatic cancer PoC 1 study and the stock’s reaction to it.
TechStock² Updates
![Asia Stock Market Today 28/08/2026 [UPDATE: 00:51 SGT] [Salesforce Leads KASE Global Into Final Minutes After Asia’s Split Close]](https://ts2.tech/wp-content/uploads/2026/08/Asia-market-dashboard-2026-08-28-0051-480x384.jpg "Asia Stock Market Today 28/08/2026 [UPDATE: 00:51 SGT] [Salesforce Leads KASE Global Into Final Minutes After Asia’s Split Close]")
